A medical worker gives a dose of monkeypox vaccine to a recipient at a monkeypox vaccination site in Los Angeles, California, the United States, on Aug. 11, 2022. (Photo by Zeng Hui/Xinhua)
LOS ANGELES, Aug. 21 (Xinhua) -- Despite a growing supply of the monkeypox vaccine in the United States, there is still no evidence that protection is reaching those most at risk, CNN reported earlier this week.
About three months into the ongoing monkeypox outbreak in the country, there are more than 12,000 cases and counting, said the report.
"But despite a growing supply of the Jynneos vaccine -- and a new strategy that could stretch the current supply five times further -- there is still no evidence that protection is reaching those most at risk," said the report.
A detailed analysis of monkeypox case records published by the U.S. Centers for Disease Control and Prevention this month offered new insight into which populations are disproportionately affected in the outbreak, including Black and Hispanic people, according to the report.
But there is still no nationwide look at who has received the vaccine, and the limited state-level data that has been made available is not promising, said the report. ■
